Back

Improvement in central haemodynamic parameters by association of angiotensin II receptors blockers and canrenone therapy in obese hypertensive patients

24 May 2016 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 4 - Renin-angiotensin-aldosterone antagonists Renin-angiotensin-aldosterone antagonists HFA Premium Access HEART FAILURE 2016

About the speaker

Photo
Doctor Carlos Alberto Paterno Marchioli

Cardiovascular Research Laboratory., Castiglion Fiorentino (AR) (Italy)

3 More presentations in this session

Presentation thumbnail
Doctor A. Giraldez Valpuesta (Jerez de la Frontera, ES)
Abstract
Presentation thumbnail
Miss M. Martin Mariscal (Madrid, ES)
Abstract Slides
Presentation thumbnail
Associate Professor P. Ameri (Genova, IT)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 4 - Renin-angiotensin-aldosterone antagonists

The Event

Event poster

HEART FAILURE 2016

24 May 2016 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Angiotensin II receptor blockers is associated a decreased left ventricular fibrosis in patients with obstructive hypertrophic cardiomyopathy
25 April 2024
thumbnail
Congress Presentation
Plasma aldosterone concentration / plasma renin activity ratio in patients with essential hypertension before treatment
26 August 2023
thumbnail
Congress Presentation
Real-world data regarding blood pressure control rates in hypertensive obese patients: a prospective, observational multicentric study performed in Romania
26 April 2024
thumbnail
Congress Presentation
The differential effects of antihypertensive drugs on central blood pressure: nebivolol versus telmisartan (ATD-CBP)
28 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources